CSF2 and cancer: ONCOS-102 is an oncolytic adenovirus genetically modified for enhanced gene delivery to cancer cells and encoding the Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF), which is a potent inducer of antitumor immunity.